Clinical-stage biotech company Antibe Therapeutics (Antibe Therapeutics Stock Quote, Charts, News, Analysts, Financials TSX:ATE) has fallen a long way over the past year, but Paradigm Capital analyst Scott McAuley is still bullish on the stock, saying in a Monday report to clients that the market isn’t taking full account of the opportunity presented by its […]
Compelling project economics and a proven, scalable design make Northstar Clean Technologies (Northstar Clean Technologies Stock Quote, Charts, News, Analysts, Financials TSXV:ROOF) one to watch for investors. That’s the news from Eight Capital analyst Sean Keaney who recently delivered one of its InnoVII Spotlight reports on the Delta, BC-based company. Founded in 2015 and first […]
Share
Tweet
Share
